Table 1.
Demographic and clinical data for patients with acute pancreatitis and control subjects
| Variable | Acute pancreatitis (n=42) | Control (n=43) | p-value |
|---|---|---|---|
| Age, years | 55.5±10.6 | 58.3±20.1 | 0.21 |
| Sex, female/male | 27/15 | 28/15 | 0.93 |
| BMI | 28.9±5.8 | 28.9±5.5 | 0.66 |
| Etiology, n (%) | |||
| Biliary | 34 (80.9) | ||
| İdiopathic | 4 (9.5) | ||
| Drug-induced | 1 (2.4) | ||
| Hypertriglyceridemia | 1 (2.4) | ||
| IPMN | 1 (2.4) | ||
| Post ERCP | 1 (2.4) | ||
| Severity, n (%) | |||
| Mild | 23 (54.8) | ||
| Moderately severe | 13 (30.9) | ||
| Severe | 6 (14.3) | ||
| Ranson criteria, median (minimum–maximum) | 1.5 (0–7) | – | |
| Local complication | 18 | – | |
| Hospital stay, day median (minimum–maximum) | 7 (4–32) | – | |
| Nil per os, day median (minimum–maximum) | 3 (2–12) | – | |
| Death, n (%) | 1 (2.4) | – |
Abbreviations: BMI, body mass index; ERCP, endoscopic retrograde colangiopancreatography; IPMN, intraductal papillary mucınous neoplasm.